OpenLegislation

Article 21 F1

United Kingdom

Original text. Later amendments are not shown.

1.

The application for the import authorisations referred to in Article 20 shall contain at least the following:

(a)

the names and addresses of the importer, the exporter of the third country F2or Northern Ireland, any other operator involved and the ultimate consignee;

(b)

the name of the scheduled substance as stated in the Annex or, in the case of a mixture or a natural product, its name and the eight-digit CN code and the name of any scheduled substance, as stated in the Annex, contained in the mixture or in the natural product;

(c)

the quantity and weight of the scheduled substance and, in the case of a mixture or a natural product, the quantity, weight, and, if available, the percentage of any scheduled substance contained therein;

(d)

if available, details of the transport arrangements, such as methods and means of transport, and date and place of envisaged import activities, and

(e)

the number of the licence or registration referred to in Articles 6 and 7.

2.

A decision on the application for an import authorisation shall be taken within a period of 15 working days from the date on which the competent authority considers the file to be complete.

Annotations

Textual amendments

F1

Regulation revoked (N.I.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), reg. 1(1), Sch.

F2

Words in Art. 21 inserted (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 6(17)

Notes on the whole EU Regulation

Textual amendments

F2

Substituted by Regulation (EU) No 1259/2013 of the European Parliament and of the Council of 20 November 2013 amending Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors.